New, Broader Antibodies Enhance HIV Treatment
Broad and Ultra-potent Anti-HIV-1 Antibodies
Tags: University of Melbourne, Australia, Healthcare & Lifesciences
Innovative anti-HIV-1 antibodies offer broader, more potent immunotherapy, surpassing existing treatments. Aimed at improving infection suppression and infected cell clearance, they address the urgent need for effective HIV management. With no current cure for HIV, affecting 38.4 million globally, this advancement presents a significant leap. These antibodies also promise a platform for rapid therapeutic antibody discovery and testing. Preclinical evaluations show promising results, marking a potential milestone in HIV therapy.
IP Type or Form Factor: Discovery & Research; Platform
TRL: 6 - prototype validated in intended environment
Industry or Tech Area: Biotechnology; Pharmaceutical Engineering
